DONGSUNG CHEMICAL Balance Sheet Health
Financial Health criteria checks 6/6
DONGSUNG CHEMICAL has a total shareholder equity of ₩525.0B and total debt of ₩177.4B, which brings its debt-to-equity ratio to 33.8%. Its total assets and total liabilities are ₩970.6B and ₩445.6B respectively. DONGSUNG CHEMICAL's EBIT is ₩81.4B making its interest coverage ratio 27.2. It has cash and short-term investments of ₩152.8B.
Key information
33.8%
Debt to equity ratio
₩177.35b
Debt
| Interest coverage ratio | 27.2x |
| Cash | ₩152.76b |
| Equity | ₩525.00b |
| Total liabilities | ₩445.61b |
| Total assets | ₩970.61b |
Recent financial health updates
Does DONGSUNG CHEMICAL (KRX:102260) Have A Healthy Balance Sheet?
Mar 25
Dongsung (KRX:102260) Seems To Use Debt Quite Sensibly
Mar 11Recent updates
Does DONGSUNG CHEMICAL (KRX:102260) Have A Healthy Balance Sheet?
Mar 25Should You Buy Dongsung Corporation (KRX:102260) For Its 3.6% Dividend?
Mar 29Dongsung (KRX:102260) Seems To Use Debt Quite Sensibly
Mar 11What Type Of Shareholders Make Up Dongsung Corporation's (KRX:102260) Share Registry?
Feb 18What Type Of Returns Would Dongsung's(KRX:102260) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 31Our Take On The Returns On Capital At Dongsung (KRX:102260)
Jan 13
Just Three Days Till Dongsung Corporation (KRX:102260) Will Be Trading Ex-Dividend
Dec 24Would Dongsung Corporation (KRX:102260) Be Valuable To Income Investors?
Dec 14Should You Use Dongsung's (KRX:102260) Statutory Earnings To Analyse It?
Nov 26Financial Position Analysis
Short Term Liabilities: A102260's short term assets (₩502.2B) exceed its short term liabilities (₩400.4B).
Long Term Liabilities: A102260's short term assets (₩502.2B) exceed its long term liabilities (₩45.3B).
Debt to Equity History and Analysis
Debt Level: A102260's net debt to equity ratio (4.7%) is considered satisfactory.
Reducing Debt: A102260's debt to equity ratio has reduced from 58.6% to 33.8% over the past 5 years.
Debt Coverage: A102260's debt is well covered by operating cash flow (75.7%).
Interest Coverage: A102260's interest payments on its debt are well covered by EBIT (27.2x coverage).